Loading…
Loading…
HCTI does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HCTI and 80,000+ other tickers.
See exactly how HCTI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HCTI and 80,000+ other tickers.
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehensive array of software, platforms, and services designed to empower healthcare and pharmaceutical organizations. These offerings help facilitate personalized treatment plans, accelerate precision medicine initiatives, drive innovation in drug discovery and development, foster collaborative research efforts, enable evidence-based decision-making, and…
AI-Powered Customer Engagement Segment Contributed $6.31 Million in Quarterly Revenue as Stockholders' Equity Climbed to $49.1 Million from $9.9 Million PLEASANTON, Calif., Aug. 13, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a technology company delivering AI-powered customer engagement and digital transformation services, is today reporting financial results for the second quarter ended June 30, 2026, which includes second quarter revenue of $9.19 million, up 158% year over year, with gross profit up 322% to $2.07 million.
Client Has Already Matched Its Full-Year 2025 Revenue by June 2026, with Annual Turnover Projected to Reach €2 Million PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that its subsidiary, Teyame Holdings Inc. ("Teyame"), has released a progress report highlighting exceptional growth achieved on behalf of a key client — one of Spain's leading health insurance companies.
Transaction introduces 27 granted international patents, 61 pending applications , and a commercial pipeline targeting over US $50 million in cumulative revenue over three years. PLEASANTON, Calif.
Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq's newly effective Market Value of Listed Securities (MVLS) requirement PLEASANTON, Calif., July 29, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that, on July 24, 2026, it completed the issuance of an aggregate of 12,546,540 shares of common stock in connection with two previously shareholder-approved transactions: the closing of its acquisition involving Teyame AI LLC and related parties (the "Teyame Transaction"), and a Share Exchange Agreement with SecureKloud Technologies Ltd.
Names Veteran Health Tech & AI Services Leader Sumit Ganguli as Chairman & CEO to Fuel Multi-Year Recurring Revenue Growth Across a Multi-Billion-Dollar Healthcare AI Market PLEASANTON, Calif., July 27, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (NASDAQ: HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary.